{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:58:28Z","timestamp":1793120308624,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013129","name":"Korea Ministry of Small and Medium Enterprises and Startups","doi-asserted-by":"publisher","award":["S3122086"],"award-info":[{"award-number":["S3122086"]}],"id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbrc.2024.150892","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T21:29:12Z","timestamp":1729718952000},"page":"150892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["6\u2032-sialyllactose prevents dexamethasone-induced muscle atrophy by controlling the muscle protein degradation pathway"],"prefix":"10.1016","volume":"736","author":[{"given":"Hiroe","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Ji","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeil","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-936X","authenticated-orcid":false,"given":"Lila","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-0454","authenticated-orcid":false,"given":"Eun Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150892_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","article-title":"Age-related diseases and clinical and public health implications for the 85 years old and over population","volume":"5","author":"Jaul","year":"2017","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbrc.2024.150892_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s10522-021-09910-5","article-title":"Aging and age\u2010related diseases: from mechanisms to therapeutic strategies","volume":"22","author":"Li","year":"2021","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbrc.2024.150892_bib3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International clinical practice guidelines for sarcopenia (icfsr): screening, diagnosis and management","volume":"22","author":"Dent","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bbrc.2024.150892_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2024.150892_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and mortality among a population-based sample of community-dwelling older adults","volume":"7","author":"Brown","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2024.150892_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150892_bib7","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms24032973","article-title":"Prevalence and mechanisms of skeletal muscle atrophy in metabolic conditions","volume":"24","author":"Jun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150892_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.11005\/jbm.2020.27.2.97","article-title":"Rodent model of muscular atrophy for sarcopenia study","volume":"27","author":"Baek","year":"2020","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bbrc.2024.150892_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jcsm.12709","article-title":"Mouse models of sarcopenia: classification and evaluation","volume":"12","author":"Xie","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2024.150892_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"L\u00f6fberg","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2024.150892_bib11","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150892_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2024.150892_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3168\/jds.S0022-0302(03)73583-8","article-title":"Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation","volume":"86","author":"Mart\u00edn-Sosa","year":"2003","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.bbrc.2024.150892_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/nure.12106","article-title":"Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides","volume":"72","author":"Ten Bruggencate","year":"2014","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bbrc.2024.150892_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.609817","article-title":"3\u2032-Sialyllactose protects SW1353 chondrocytic cells from interleukin-1\u03b2-induced oxidative stress and inflammation","volume":"12","author":"Baek","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150892_bib16","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1002\/fsn3.3559","article-title":"3\u2032sialyllactose and 6\u2032sialyllactose enhance performance in endurance-type exercise through metabolic adaptation","volume":"11","author":"Arellano Spadaro","year":"2023","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.bbrc.2024.150892_bib17","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3390\/nu16162600","article-title":"6\u2032-Sialyllactose enhances exercise performance via increased muscle mass and strength","volume":"16","author":"Park","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2024.150892_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115689","article-title":"Pharmacokinetics and clinical efficacy of 6\u2032-sialyllactose in patients with GNE myopathy: randomized pilot trial","volume":"168","author":"Park","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2024.150892_bib19","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/brain\/awu210","article-title":"Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice","volume":"137","author":"Yonekawa","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2024.150892_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jcsm.12393","article-title":"Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism","volume":"10","author":"Shen","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2024.150892_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1139\/bcb-2020-0445","article-title":"Role of SIRT2 in regulating the dexamethasone-activated autophagy pathway in skeletal muscle atrophy","volume":"99","author":"Han","year":"2021","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.bbrc.2024.150892_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115664","article-title":"Oxidative stress: roles in skeletal muscle atrophy","volume":"214","author":"Zhang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150892_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09168451.2015.1075861","article-title":"Anti-skeletal muscle atrophy effect of Oenothera odorata root extract via reactive oxygen species-dependent signaling pathways in cellular and mouse model","volume":"80","author":"Lee","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrc.2024.150892_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/ijms21031111","article-title":"MicroRNA 322 aggravates dexamethasone-induced muscle atrophy by targeting IGF1R and INSR","volume":"21","author":"Geng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150892_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yrtph.2018.03.010","article-title":"Toxicological evaluation of 6\u2032-sialyllactose (6\u2019-SL) sodium salt","volume":"95","author":"Gurung","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150892_bib26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/nu12041030","article-title":"Evaluation of 6\u2032-sialyllactose sodium salt supplementation to formula on growth and clinical parameters in neonatal piglets","volume":"12","author":"Monaco","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2024.150892_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105110","article-title":"Randomized, triple-blind, placebo-controlled study to evaluate the safety of 6\u2032-Sialyllactose in healthy adults","volume":"129","author":"Kim","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24014281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24014281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:58:08Z","timestamp":1732082288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24014281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S0006291X24014281"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150892","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6\u2032-sialyllactose prevents dexamethasone-induced muscle atrophy by controlling the muscle protein degradation pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150892"}}